21 results
424B5
MEIP
MEI Pharma Inc
28 Feb 24
Prospectus supplement for primary offering
4:04pm
inflation and the increase in interest rates as a result;
potential economic downturn;
activist investors;
our inability to maintain or enter
8-K
EX-99.1
MEIP
MEI Pharma Inc
13 Feb 24
MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights
5:05pm
as a result; potential economic downturn; geopolitical conflicts; activist investors; our inability to maintain or enter into, and the risks resulting
8-K
EX-99.1
MEIP
MEI Pharma Inc
11 Dec 23
MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023
4:00pm
of rising inflation and the increase in interest rates as a result; potential economic downturn; activist investors; our inability to maintain or enter
8-K
EX-99.1
qhy8x
9 Nov 23
MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights
4:06pm
DFAN14A
rpzg4oyv1q1ujoig
1 Nov 23
Additional proxy materials by non-management
5:15pm
DEFA14A
ctzk0 74ep
1 Nov 23
Additional proxy soliciting materials
4:54pm
8-K
EX-10.1
v6tq8cee6pa8bv8
1 Nov 23
MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital
4:01pm
8-K
EX-99.1
kgtuack7nizeimj f33
1 Nov 23
MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital
4:01pm
DEFA14A
gr60 y1pbna896jv6dk
18 Oct 23
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
4omw 82ef0
3 Oct 23
Entry into a Material Definitive Agreement
6:04am
DEFA14A
j94886xzn6xua
2 Oct 23
Additional proxy soliciting materials
5:27pm
DEFA14A
4g9hmjqghth b0ju
28 Sep 23
Additional proxy soliciting materials
5:17pm
8-K
EX-99.1
8d1wlams03vkchaab1bt
26 Sep 23
MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights
4:31pm
DEFA14A
p0brxf2hdq4spnlwq5o0
18 Sep 23
Additional proxy soliciting materials
4:16pm
424B3
04yrplxune7m6g0
6 Jun 23
Prospectus supplement
4:19pm